The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate
Prostate Cancer
Study Type
Study Phase
Study Design
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Name: Goldlock Type: Device
Name: Visicoil smallest size Type: Device
Name: Visicoil larger size Type: Device
Name: Bard goldmarker smallest size Type: Device
Name: Bard goldmarker larger size Type: Device
Overall Status
Implantation of fiducial markers in the prostate and daily check of the positioning during radiotherapy based on the implanted fiducial markers
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Male
Criteria: Inclusion Criteria:

- histological proven adenocarcinoma of the prostate

- T1-T4 tumors

- Radiotherapy as primary therapy +/- androgen deprivation

- Presence of an intraprostatic lesion (IPL) on MRI/MRS

- Presence of an intraprostatic lesion (IPL) on ultrasound

- WHO 0-2

Exclusion Criteria:

- Other primary tumor, except non-melanoma skin cancer

- No written informed consent
University Hospital Ghent
Ghent, Belgium
Status: Recruiting
Start Date
December 2008
Completion Date
May 2015
University Hospital, Ghent
University Hospital, Ghent
Record processing date processed this data on July 28, 2015 page